PiLSL: pairwise interaction learning-based graph neural network for synthetic lethality prediction in human cancers

Xin Liu1, Jiale Yu1, Siyu Tao1

  • 1School of Information Science and Technology, Shanghai Tech University, Shanghai 201210, China.

Abstract

Insights

Synthetic lethality (SL) is a cancer therapy target. PiLSL, a novel graph neural network, predicts SL interactions by learning gene pair representations and elucidating mechanisms.

Area of Science:

  • Computational biology
  • Genomics
  • Bioinformatics

Background:

  • Synthetic lethality (SL) offers novel anti-cancer therapeutic targets.
  • Current methods often overlook gene pairwise interactions and lack mechanistic insights.
  • Machine learning approaches typically focus on individual gene representations.

Purpose of the Study:

  • To develop a novel graph neural network (GNN) model, PiLSL, for predicting synthetic lethality.
  • To enhance SL prediction by learning pairwise gene interactions.
  • To provide mechanistic explanations for SL interactions.

Main Methods:

  • Constructing enclosing graphs for gene pairs from knowledge graphs.
  • Employing an attentive embedding propagation layer within a GNN to learn weighted gene pair representations.
  • Integrating latent features with multi-omics data for robust gene representation.

Main Results:

  • PiLSL significantly outperforms existing baseline methods in SL prediction.
  • The model demonstrates strong generalization capabilities across diverse scenarios.
  • PiLSL offers interpretable insights into SL mechanisms through attention-weighted paths.

Conclusions:

  • PiLSL effectively predicts synthetic lethality by focusing on pairwise gene interactions.
  • The model's interpretability aids in understanding SL mechanisms.
  • PiLSL advances the translation of synthetic lethality into cancer therapeutics.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
428